Documentos relacionados

1. Latest advances in the efficacy, tolerability, and monotherapy of integrase inhibitors.
2. Comparison of weight gain after antiretroviral switch to integrase strand transfer inhibitor or tenofovir alafenamide-based therapy.
3. Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir.
4. Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study.
5. Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting.
6. Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study.
7. Perfil de seguridad de dolutegravir
8. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
9. Resistance Testing for Integrase Strand Transfer Inhibitors in Naive, Human Immunodeficiency Virus-infected Individuals.
10. [Medical Care of people living with HIV in the Instituto Mexicano del Seguro Social].